TIL therapy manufacturing infographic
Addressing common challenges at each stage of the workflow.
Addressing common challenges at each stage of the workflow.
From regulatory support to scientific support, here’s how we can help.
These misconceptions can potentially hinder the successful execution of an MES for cell therapy.
It is never too early to start to document processes and gear data collection towards compliance.
As the biopharmaceutical industry continues to grow, the demand for skilled workers increases.
Here, we describe a workflow that produces primary human NK cells at clinically relevant scale.
A robust workflow that can be adapted for cGMP compliance in commercial production.
Allogeneic cell therapies are poised to extend the life-changing benefits to many.
Secure your workflow of today—and tomorrow—to get your cell therapy safely to patients.
Biomanufacturing platforms and services for cell therapies, plasmids, and viral vectors.
Scale with controlled, consistent, and traceable cryopreservation, logistics, and thawing.
Maintain process control when scaling cell therapies.